sitagliptin glp 1 New GLP-1 Guidelines for Type 2 Diabetes in 2025 Glucagon-like peptide 1 in health
Description
2025;44(1):200
This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes
GLP-1 and GIP are incretin hormones that help regulate blood sugar and appetite
No Injections Needed
Increasing infertility rates represent a growing medical challenge in modern societies resulting from a complex interplay of sociocultural trends, lifestyle factors, exposure to environmental toxins, and underlying health problems
